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The prevalence of chronic
spontaneous urticaria (CSU) in the
pediatric populationTo the Editor: I read with interest the recent article by
Rosman et al,1 which assessed the prevalence data
and clinical characterization of chronic urticaria in
adolescents, by taking advantage of the medical
records of the mandatory military medical screening
in Israel. Based on thesemedical records of 1,108,833
consecutive 16-year-old conscripts undergoing
military visits from 1996 until 2015, these authors
retrieved data for 6617 adolescents (0.6% of the total)
diagnosed with chronic spontaneous urticaria
(CSU).1
According to the most updated definition, CSU is
characterized by the ‘‘spontaneous appearance of
wheals, angioedema or both for[6 weeks due to
known ( for example, auto-reactivity that is the
presence of mast cell-activating auto-antibodies) or
unknown causes.’’2 The authors stated they
excluded all forms of inducible or secondary
urticaria and described the comorbidities of CSU in
their cohort of adolescents, without suggesting or
discussing any pathophysiologic link or causal
relationship between 2 associated clinical condi-
tions.1 Indeed, for instance, the fact of being
asthmatic does not exclude necessarily the diagnosis
of CSU in a patient with chronic urticaria. However, it
is equally true that the epidemiologic analysis and
methodology of this study may not have afforded the
authors the ability to always establish the precise
diagnostic conclusions about the specific form of
chronic urticaria in each affected patient.
Therefore, inmy opinion, the yearly prevalence of
0.4% to 0.8% extrapolated by the authors may not
refer to CSU only,1 because there is the possibility
that other forms of chronic urticaria might be
included as well in this count due to the study
methodology.
According to different studies, the prevalence of
chronic urticaria in the pediatric population ranges
from 0.1% up to 3%. Pediatric CSU is considered to be
much less prevalent than in adults. Previous articlesJ AM ACAD DERMATOLsuggested an overall prevalence not greater than
0.1% to 0.3% in children.3,4
However, despite several limitations (discussed
here and by the authors themselves), this study
emphasizes that the prevalence of CSU in the
pediatric population may be higher than previously
thought. Indeed, a recent study by Netchiporouk
et al5 described a cohort of 139 consecutive children
diagnosed with chronic urticaria and, actually,
approximately 85% received a diagnosis of CSU,
thus widely concluding that CSU is themost common
form of chronic urticaria in the pediatric population.
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